Your browser is no longer supported. Please, upgrade your browser.
Settings
CDNA [NASD]
CareDx, Inc
Index- P/E- EPS (ttm)-0.35 Insider Own1.70% Shs Outstand52.68M Perf Week-1.59%
Market Cap2.35B Forward P/E117.98 EPS next Y0.37 Insider Trans-16.17% Shs Float51.77M Perf Month-12.08%
Income-18.00M PEG- EPS next Q0.15 Inst Own- Short Float6.79% Perf Quarter-43.85%
Sales275.80M P/S8.51 EPS this Y22.70% Inst Trans1.76% Short Ratio5.01 Perf Half Y-46.50%
Book/sh8.96 P/B4.83 EPS next Y8.58% ROA-3.60% Target Price99.33 Perf Year-27.25%
Cash/sh6.71 P/C6.46 EPS next 5Y20.00% ROE-4.20% 52W Range39.16 - 99.83 Perf YTD-40.23%
Dividend- P/FCF- EPS past 5Y19.00% ROI-6.00% 52W High-57.14% Beta0.51
Dividend %- Quick Ratio6.10 Sales past 5Y46.80% Gross Margin67.60% 52W Low9.27% ATR3.25
Employees456 Current Ratio6.40 Sales Q/Q41.60% Oper. Margin-6.30% RSI (14)35.82 Volatility6.03% 5.63%
OptionableYes Debt/Eq0.00 EPS Q/Q-292.70% Profit Margin-6.50% Rel Volume0.97 Prev Close43.30
ShortableYes LT Debt/Eq0.00 EarningsOct 28 AMC Payout- Avg Volume701.88K Price42.79
Recom1.70 SMA20-4.55% SMA50-24.63% SMA200-40.52% Volume448,356 Change-1.18%
Jul-20-21Resumed BTIG Research Buy $115
Jun-03-21Initiated Goldman Buy $95
Feb-26-21Downgrade H.C. Wainwright Buy → Neutral
Oct-30-20Reiterated H.C. Wainwright Buy $47 → $55
Oct-08-20Reiterated H.C. Wainwright Buy $45 → $47
Oct-02-20Reiterated H.C. Wainwright Buy $40 → $45
Aug-05-20Reiterated H.C. Wainwright Buy $37 → $40
Jun-26-20Initiated BTIG Research Buy $40
Jun-19-20Reiterated H.C. Wainwright Buy $40 → $37
Oct-01-19Resumed Craig Hallum Buy $48
May-09-19Upgrade H.C. Wainwright Neutral → Buy $30 → $43
Feb-15-19Initiated Jefferies Buy $35
Oct-23-18Resumed Raymond James Strong Buy $30
Sep-18-18Reiterated H.C. Wainwright Neutral $17 → $22
Nov-27-17Initiated H.C. Wainwright Buy $12
Jun-14-16Reiterated Mizuho Buy $12 → $8
Sep-29-15Downgrade Raymond James Outperform → Mkt Perform
Sep-25-15Initiated Craig Hallum Buy
Mar-18-15Reiterated Mizuho Buy $15 → $12
Dec-02-21 09:00PM  
06:38PM  
06:33PM  
10:00AM  
07:00AM  
Dec-01-21 06:32PM  
06:32PM  
09:11AM  
07:09AM  
Nov-30-21 06:23PM  
10:05AM  
Nov-29-21 06:02PM  
06:57AM  
Nov-28-21 08:22AM  
Nov-27-21 05:00AM  
Nov-26-21 06:24PM  
10:12AM  
Nov-25-21 06:18PM  
Nov-24-21 07:33PM  
06:12PM  
Nov-23-21 08:07PM  
04:42PM  
05:26AM  
Nov-22-21 02:29PM  
11:34AM  
10:00AM  
Nov-21-21 08:22AM  
Nov-19-21 06:21PM  
10:30AM  
07:00AM  
Nov-18-21 06:19PM  
02:00PM  
11:49AM  
10:15AM  
09:36AM  
07:00AM  
Nov-17-21 10:00PM  
02:52PM  
11:30AM  
10:00AM  
Nov-16-21 06:12PM  
01:51PM  
01:15PM  
09:50AM  
Nov-15-21 08:00PM  
06:04PM  
05:29PM  
04:28PM  
04:05PM  
03:34PM  
12:07PM  
01:00AM  
Nov-14-21 09:39AM  
Nov-12-21 06:04PM  
06:00PM  
04:06PM  
03:31PM  
10:30AM  
Nov-11-21 06:02PM  
Nov-10-21 11:46AM  
09:45AM  
07:00AM  
Nov-09-21 06:12PM  
04:00PM  
02:29PM  
10:00AM  
Nov-08-21 07:00PM  
06:02PM  
04:54PM  
02:17PM  
12:00PM  
11:23AM  
10:27AM  
09:55AM  
Nov-07-21 08:22AM  
Nov-06-21 06:10AM  
Nov-05-21 06:26PM  
03:55PM  
03:45PM  
02:43PM  
12:00PM  
09:40AM  
Nov-04-21 06:02PM  
02:42PM  
12:01PM  
09:45AM  
07:00AM  
Nov-03-21 09:00PM  
03:00PM  
02:47PM  
02:39PM  
01:21PM  
01:00PM  
12:00PM  
09:43AM  
09:00AM  
07:00AM  
01:00AM  
Nov-02-21 09:00PM  
06:52PM  
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development and commercialization rights to NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dhingra AnkurChief Financial OfficerNov 24Buy42.345,000211,6945,000Nov 29 04:19 PM
Goldberg MichaelDirectorNov 09Option Exercise1.2250061061,068Nov 10 04:47 PM
Goldberg MichaelDirectorNov 09Sale47.5450023,77060,568Nov 10 04:47 PM
Maag PeterDirectorNov 05Option Exercise18.9010,000188,969351,756Nov 09 06:01 PM
TORRES ARTHUR ADirectorNov 05Buy47.6260028,5722,855Nov 09 05:47 PM
Maag PeterDirectorNov 05Sale49.4010,000494,000341,756Nov 09 06:01 PM
Goldberg MichaelDirectorOct 11Option Exercise1.2250061061,068Oct 12 05:19 PM
Goldberg MichaelDirectorOct 11Sale62.5050031,25160,568Oct 12 05:19 PM
Maag PeterExecutive ChairOct 05Option Exercise18.1710,000181,661351,756Oct 06 07:40 PM
Maag PeterExecutive ChairOct 05Sale64.6710,000646,735341,756Oct 06 07:40 PM
Maag PeterExecutive ChairSep 07Option Exercise10.653,44836,718351,756Sep 07 08:36 PM
Maag PeterExecutive ChairSep 07Sale73.6810,000736,763341,756Sep 07 08:36 PM
Seeto ReginaldSee RemarksAug 27Sale80.0065852,642142,534Aug 27 04:43 PM
Seeto ReginaldSee RemarksAug 11Option Exercise27.7210,821299,958143,192Aug 17 06:59 PM
Maag PeterExecutive ChairAug 05Option Exercise11.364,95856,333354,256Aug 09 04:56 PM
Maag PeterExecutive ChairAug 05Sale83.1310,000831,313349,298Aug 09 04:56 PM
Seeto ReginaldSee RemarksJul 08Sale85.675,994513,503132,634Jul 09 07:28 PM
Maag PeterExecutive ChairJul 06Option Exercise12.242,31228,299374,256Jul 07 06:31 PM
Maag PeterExecutive ChairJul 06Sale90.7010,000907,002364,256Jul 07 06:31 PM
Seeto ReginaldSee RemarksJun 28Option Exercise26.8413,212354,613145,583Aug 17 06:59 PM
Seeto ReginaldSee RemarksJun 28Sale95.7513,2121,264,990132,371Aug 17 06:59 PM
Maag PeterExecutive ChairJun 25Option Exercise24.353959,618372,339Jun 25 07:54 PM
Seeto ReginaldSee RemarksJun 25Option Exercise26.539,210244,359141,581Aug 17 06:59 PM
Seeto ReginaldSee RemarksJun 25Sale95.159,210876,318132,371Aug 17 06:59 PM
Maag PeterExecutive ChairJun 25Sale95.0039537,525371,944Jun 25 07:54 PM
Maag PeterExecutive ChairJun 24Option Exercise23.769,605228,217381,549Jun 25 07:54 PM
Maag PeterExecutive ChairJun 24Sale95.309,605915,398371,944Jun 25 07:54 PM
Seeto ReginaldSee RemarksJun 09Option Exercise26.5616,718444,066159,352Jun 11 05:51 PM
Maag PeterExecutive ChairJun 09Option Exercise24.352,52261,411374,466Jun 11 05:52 PM
HAGSTROM WILLIAM ADirectorJun 09Option Exercise4.955,00024,75023,575Jun 11 05:52 PM
King SashaChief Marketing OfficerJun 09Option Exercise5.255,05526,52052,574Jun 11 05:51 PM
King SashaChief Marketing OfficerJun 09Sale90.0112,4351,119,26340,139Jun 11 05:51 PM
HAGSTROM WILLIAM ADirectorJun 09Sale88.145,000440,70618,575Jun 11 05:52 PM
Maag PeterExecutive ChairJun 09Sale90.002,522226,982371,944Jun 11 05:52 PM
Seeto ReginaldSee RemarksJun 09Sale90.0116,7181,504,819142,634Jun 11 05:51 PM
Maag PeterExecutive ChairJun 08Option Exercise24.3597823,814372,922Jun 09 08:27 PM
King SashaChief Marketing OfficerJun 08Option Exercise16.041,00016,03748,519Jun 09 08:30 PM
Seeto ReginaldSee RemarksJun 08Option Exercise27.7250013,860143,134Jun 09 08:32 PM
Seeto ReginaldSee RemarksJun 08Sale90.0050045,001142,634Jun 09 08:32 PM
King SashaChief Marketing OfficerJun 08Sale90.021,00090,02447,519Jun 09 08:30 PM
Maag PeterExecutive ChairJun 08Sale90.0597888,074371,944Jun 09 08:27 PM
King SashaChief Marketing OfficerJun 07Option Exercise20.138,071162,43855,590Jun 08 06:37 PM
Seeto ReginaldSee RemarksJun 07Option Exercise27.729,973276,452152,607Jun 08 06:39 PM
Maag PeterExecutive ChairJun 07Option Exercise19.377,592147,021398,444Jun 08 06:41 PM
Maag PeterExecutive ChairJun 07Sale86.2526,5002,285,752371,944Jun 08 06:41 PM
Seeto ReginaldSee RemarksJun 07Sale90.019,973897,644142,634Jun 08 06:39 PM
King SashaChief Marketing OfficerJun 07Sale90.018,071726,46147,519Jun 08 06:37 PM
SNYDERMAN RALPHDirectorJun 02Sale81.572,511204,81551,015Jun 10 05:32 PM
SNYDERMAN RALPHDirectorJun 01Sale77.302,512194,17353,526Jun 10 05:32 PM
SNYDERMAN RALPHDirectorMay 28Sale81.082,511203,59556,038Jun 10 05:32 PM
SNYDERMAN RALPHDirectorMay 27Sale81.011,966159,26658,549Jun 10 05:32 PM
Maag PeterExecutive ChairMay 25Option Exercise27.1710,000271,700419,444May 27 05:04 PM
Maag PeterExecutive ChairMay 25Sale80.5910,000805,871409,444May 27 05:04 PM
Bickerstaff GeorgeDirectorMay 21Sale75.3410,000753,37360,938May 21 07:50 PM
HAGSTROM WILLIAM ADirectorMay 14Option Exercise5.4110,00054,13828,575May 17 04:16 PM
HAGSTROM WILLIAM ADirectorMay 14Sale66.8910,000668,88418,575May 17 04:16 PM
Bickerstaff GeorgeDirectorMay 12Sale63.0710,000630,74770,938May 13 09:11 PM
Maag PeterExecutive ChairMay 11Option Exercise12.2487,1281,066,447496,572May 12 06:53 PM
Goldberg MichaelDirectorMay 11Option Exercise2.9549,083144,574107,586May 12 06:56 PM
Goldberg MichaelDirectorMay 11Sale66.6049,0833,268,97258,503May 12 06:56 PM
Maag PeterExecutive ChairMay 11Sale66.6087,1285,802,799409,444May 12 06:53 PM
Maag PeterExecutive ChairMay 10Option Exercise9.6126,293252,741435,737May 12 06:53 PM
Goldberg MichaelDirectorMay 10Option Exercise2.9515,44245,48473,945May 12 06:56 PM
Goldberg MichaelDirectorMay 10Sale68.9415,4421,064,56158,503May 12 06:56 PM
Maag PeterExecutive ChairMay 10Sale68.9426,2931,812,623409,444May 12 06:53 PM
Maag PeterExecutive ChairMay 05Option Exercise27.1710,000271,700419,444May 06 08:55 PM
Maag PeterExecutive ChairMay 05Sale73.3210,000733,192409,444May 06 08:55 PM
Maag PeterExecutive ChairMay 03Option Exercise19.8715,086299,778428,054May 04 06:55 PM
Maag PeterExecutive ChairMay 03Sale76.6420,0001,532,723408,054May 04 06:55 PM
Maag PeterExecutive ChairApr 05Sale72.4010,000724,015412,968Apr 06 04:29 PM
Maag PeterExecutive ChairMar 05Sale61.2910,000612,852422,968Mar 05 08:45 PM
Seeto ReginaldSee RemarksMar 01Sale85.4510,704914,700142,634Mar 01 04:23 PM
Maag PeterExecutive ChairFeb 05Sale89.8210,000898,190412,800Feb 05 07:21 PM
SNYDERMAN RALPHDirectorJan 15Sale88.8812,0001,066,51372,672Jan 19 08:58 AM
King SashaChief Commercial OfficerJan 14Option Exercise9.209,87590,86653,306Jan 15 05:21 PM
King SashaChief Commercial OfficerJan 14Sale87.559,875864,59143,431Jan 15 05:21 PM
Cohen Fred EDirectorJan 06Option Exercise14.7415,000221,100105,893Jan 06 08:37 PM
Maag PeterExecutive ChairJan 05Option Exercise6.3110,00063,100431,974Jan 06 06:01 PM
Maag PeterExecutive ChairJan 05Sale71.9210,000719,237421,974Jan 06 06:01 PM
Seeto ReginaldSee RemarksDec 18Sale68.018,363568,801114,035Dec 18 08:40 PM
Goldberg MichaelDirectorDec 14Sale70.1930,0002,105,72257,404Dec 14 07:57 PM
Bickerstaff GeorgeDirectorDec 14Sale71.7610,000717,64480,487Dec 14 07:50 PM
Maag PeterExecutive ChairDec 07Option Exercise6.3110,00063,100431,974Dec 08 04:06 PM
Maag PeterExecutive ChairDec 07Sale66.3710,000663,667421,974Dec 08 04:06 PM